Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Treatment Effects of Narrative Exposure Therapy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2008 by University of Bergen.
Recruitment status was:  Recruiting
Norwegian Center for Violence and Traumatic Stress Studies
Information provided by:
University of Bergen Identifier:
First received: April 10, 2008
Last updated: April 15, 2008
Last verified: April 2008
This study compares Narrative Exposure Therapy with a Waiting list control group, both consists of traumatized patients with diagnosed Posttraumatic Stress Disorder. The main aim is to investigate if the patients psychiatric symptoms and levels of the stress hormone cortisol will improve more after Narrative Exposure Therapy than the Waiting list (i.e. no intervention).

Condition Intervention Phase
Posttraumatic Stress Disorder
Behavioral: Narrative Exposure Therapy
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Treatment Effects of Narrative Exposure Therapy on Psychiatric Symptoms and Cortisol Levels in Patients With Posttraumatic Stress Disorder

Resource links provided by NLM:

Further study details as provided by University of Bergen:

Primary Outcome Measures:
  • Psychiatric symptoms [ Time Frame: 1 and 6 months after treatment ]

Secondary Outcome Measures:
  • Cortisol in saliva [ Time Frame: 1 and 6 months after treatment ]

Estimated Enrollment: 40
Study Start Date: May 2007
Estimated Study Completion Date: November 2010
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A
Treatment group, receives Narrative Exposure Therapy immediately after first assessment. Patients are assessed 1 and 6 months after treatment.
Behavioral: Narrative Exposure Therapy
Psychological treatment, with narration of positive and traumatic events in patients history, including "in vivo" exposure of traumatic events. The narrative is written down by the therapist.
Other Name: NET
No Intervention: B
Waiting list control group, receives no intervention for 3 months after first assessment. A second assessment is then administered and patients receives Narrative Exposure Therapy. Patients are assessed 1 and 6 months after treatment.

Detailed Description:
In this study we want to compare Narrative Exposure Therapy (NET) to Waiting list controls. Adult patients with diagnosed Posttraumatic Stress Disorder following different types of trauma, will be included. Clinicians in psychiatric outpatient clinics will treat patients with NET, either immediately after assessment, or after a second assessment 3 months later. All patients will also be assessed 1 and 6 months after treatment completion. All patients will be assessed for psychiatric symptoms by the Mini International Neuropsychiatric Interview (version 5.0.0) and the Clinician-Administered PTSD Scale. Patients will also answer several questionnaires (IES-R, SCL-90, BDI-II, DES and UCL). Baseline level of the stress hormone cortisol will be collected in saliva for measuring the diurnal cycle. We will investigate if patients with Posttraumatic Stress Disorder will show more symptom improvement with NET than those on the waiting list (i.e. no intervention) in addition to measuring potential differences in cortisol between the groups.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Posttraumatic Stress Disorder (PTSD)
  • Age above 18 years
  • Understands, speaks and writes Norwegian
  • Informed, written consent

Exclusion Criteria:

  • Active psychosis
  • Active suicidality
  • Serious self mutilation
  • Active alcohol or drug abuse
  • Serious dissociative symptoms
  • Disease in nervous system or head injury
  • Hormonal disease
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00660439

Contact: Tove S. Nordling, Cand Psychol +47 55976691

Western Norway Violence and Traumatic Stress Resource Centre Recruiting
Bergen, Norway, 5021
Contact: Tove S. Nordling, Cand Psychol    +47 55 97 66 91   
Sub-Investigator: Tove S. Nordling, Cand Psychol         
Sponsors and Collaborators
University of Bergen
Norwegian Center for Violence and Traumatic Stress Studies
Study Director: Anne Marita Milde, PhD University of Bergen
  More Information

Responsible Party: PhD Anne Marita Milde, University of Bergen, Department of Biological and Medical Psychology Identifier: NCT00660439     History of Changes
Other Study ID Numbers: NET 40
Study First Received: April 10, 2008
Last Updated: April 15, 2008

Keywords provided by University of Bergen:

Additional relevant MeSH terms:
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Trauma and Stressor Related Disorders
Mental Disorders processed this record on April 28, 2017